covid-19 vaccine patient

AstraZeneca asks FDA to authorize antibody treatment to prevent COVID-19

Reading now: 810
www.fox29.com

RELATED: Hard-hit states skyrocketing demand for COVID-19 antibody drugsThe FDA has stressed that antibody drugs are not a substitute for vaccination, which is the most effective, long-lasting form of virus protection.

Antibody drugs also are expensive to produce and require an IV or injection and health care workers to administer.Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77%.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA